Target intelligence / Profile preview

Bacterial cell envelope and intracellular contents

Molecular classification
Complex biological structure, Multi-component system
01

Overview

The bacterial cell envelope and intracellular contents encompass the entire structural and functional apparatus of a bacterium, serving as the fundamental site of action for all antibacterial therapies. The cell envelope consists of the inner cytoplasmic membrane, the peptidoglycan cell wall, and, in Gram-negative bacteria, an additional outer membrane, all of which maintain osmotic pressure and regulate molecular transport (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). Within this envelope, the intracellular environment contains the genetic material (nucleoid), ribosomes for protein synthesis, and metabolic enzymes essential for growth and replication (Miller et al., 2014, Cold Spring Harb Perspect Med). Therapeutic intervention typically involves small molecules that exploit the biochemical differences between bacterial and eukaryotic cells, such as the unique structure of peptidoglycan or the specific sedimentation coefficients of bacterial ribosomes (Kohanski et al., 2010, Nat Rev Microbiol). Disruption of these components leads to bacteriostatic or bactericidal effects, making them the primary focus in treating infectious diseases ranging from minor skin infections to life-threatening sepsis. However, the complexity and adaptability of these structures contribute significantly to the global challenge of antimicrobial resistance, as bacteria evolve mechanisms to shield or modify these targets (Brown & Wright, 2016, Nature).

Other names
Bacterial cell structureBacterial cell wall and cytoplasmBacterial cell components
02

Mechanism of action

Antibacterial agents target these components through various pathways: beta-lactams and glycopeptides inhibit peptidoglycan synthesis in the cell wall; polymyxins and lipopeptides disrupt the integrity of the cytoplasmic or outer membranes; aminoglycosides, tetracyclines, and macrolides bind to ribosomal subunits to inhibit protein synthesis; and fluoroquinolones inhibit DNA topoisomerases within the intracellular space (Kohanski et al., 2010, Nat Rev Microbiol; Brown & Wright, 2016, Nature).

03

Biological functions

Structural integrityPermeability barrierProtein synthesisDNA replicationMetabolism
04

Disease associations

InfectionSepsisPneumoniaUrinary tract infection
05

Safety considerations

Potential for off-target toxicity in host tissues (e.g., nephrotoxicity and ototoxicity) (Blair et al., 2015, Nat Rev Microbiol)Disruption of the protective human microbiome leading to secondary infections like Clostridioides difficile (Blair et al., 2015, Nat Rev Microbiol)Rapid emergence of multi-drug resistant bacterial strains (Brown & Wright, 2016, Nature)
06

Interacting drugs

Penicillin

5 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC) (Lamy et al., 2020, Lancet Infect Dis)Procalcitonin (PCT) (Lamy et al., 2020, Lancet Infect Dis)C-reactive protein (CRP) (Lamy et al., 2020, Lancet Infect Dis)Molecular detection of resistance genes (e.g., mecA, blaNDM-1) (Lamy et al., 2020, Lancet Infect Dis)

Beyond the preview

Go deeper on Bacterial cell envelope and intracellular contents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell envelope and intracellular contents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call